Tianjin Lisheng Pharmaceutical Co.,Ltd.
Shenzhen Stock Exchange 002393.SZ
Tianjin Lisheng Pharmaceutical Co.,Ltd. Market Capitalization on January 14, 2025: USD 589.74 M
Tianjin Lisheng Pharmaceutical Co.,Ltd. Market Capitalization is USD 589.74 M on January 14, 2025, a -9.91% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
-
Tianjin Lisheng Pharmaceutical Co.,Ltd. 52-week high Market Capitalization is USD 683.66 M on May 09, 2024, which is 15.93% above the current Market Capitalization.
-
Tianjin Lisheng Pharmaceutical Co.,Ltd. 52-week low Market Capitalization is USD 379.85 M on July 24, 2024, which is -35.59% below the current Market Capitalization.
-
Tianjin Lisheng Pharmaceutical Co.,Ltd. average Market Capitalization for the last 52 weeks is USD 558.34 M.
Key data
| Date | Market Capitalization | Share Price | Price to Earnings Ratio (P/E) | Price to Sales Ratio (P/S) |
|---|
Market news
Loading...
Shenzhen Stock Exchange: 002393.SZ
| CEO | Mr. Fujun Wang |
| IPO Date | April 23, 2010 |
| Location | China |
| Headquarters | No.16, Saida North 1st Road |
| Employees | 1,328 |
| Sector | Health Care |
| Industries | |
Description
Tianjin Lisheng Pharmaceutical Co.,Ltd. engages in the production and sale of chemical medicines. The company offers tablets, hard capsules, dripping pills, freeze-dried powder injections, water injections, and bulk medicines, as well as intermediates, diagnostic reagents, biochemical reagents, and plastic bottles. It also exports its products. The company is based in Tianjin, China. Tianjin Lisheng Pharmaceutical Co.,Ltd. operates as a subsidiary of Tianjin Pharmaceutical Holdings Co., Ltd.
Key trends
Past 5 years
Similar companies
Harbin Gloria Pharmaceuticals Co., Ltd
USD 0.34
5.49%
Zhejiang Xianju Pharmaceutical Co.,Ltd.
USD 1.34
1.98%
Jinghua Pharmaceutical Group Co., Ltd.
USD 1.01
2.22%
StockViz Staff
January 15, 2025
Any question? Send us an email